Role of metabolites derived from gut microbiota in inflammatory bowel disease

doi:10.12998/wjcc.v10.i9.2660

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 9

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6680)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

421

WORD

101

HTML

3963

Figures (1-1)

309

Sum=4794

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

210

Download

459

Sum=669

Publishing Process of This Article

Item

Count

Browse

352

Download

865

Sum=1217

Mar 26, 2022 (publication date) through Jan 10, 2025

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Cases. Mar 26, 2022; 10(9): 2660-2677
Published online Mar 26, 2022. doi: 10.12998/wjcc.v10.i9.2660

Open in New Tab Full Size Figure Download Figure

Figure 1 The cycle of circular causality in inflammatory bowel disease. FMT: Fecal microbiota transplantation; SCFAs: Short chain fatty acids.

Citation: Zheng L, Wen XL, Duan SL. Role of metabolites derived from gut microbiota in inflammatory bowel disease. World J Clin Cases 2022; 10(9): 2660-2677
URL: https://www.wjgnet.com/2307-8960/full/v10/i9/2660.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i9.2660